期刊文献+

高脂血症的药物治疗与非药物干预 被引量:2

下载PDF
导出
摘要 大量研究证明血清总胆固醇(TC)、三酰甘油(TG)升高,特别是低密度脂蛋白胆固醇(LDL-C)的升高,是诱发动脉硬化和冠心病的重要因素,选择高效低毒的降脂药物对高脂血症进行治疗在冠心病一级、二级预防中起着重要作用。鉴于目前多种他汀类降脂药物价格昂贵,使许多冠心病(CHD)及CHD危重症患者难以长期坚持服用。
作者 米占山
出处 《中国医药指南》 2010年第13期199-200,共2页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献25

  • 1张刚,沐贤友,曹雪滨,黄雄,毛继康,汪明慧.血脂康和阿托伐他汀治疗混合型高血脂症的研究[J].现代中西医结合杂志,2005,14(2):154-155. 被引量:5
  • 2漆满英,章璟,肖建纲.血脂康治疗高胆固醇血症112例疗效观察[J].实用临床医学(江西),2004,5(6):20-20. 被引量:4
  • 3李长龄,中国药理学会通讯,1995年,12卷,12页
  • 4Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults indings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation, 2003, 107: 2185-2189.
  • 5He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004, 110(4): 405-411.
  • 6Expert Panel on Detection, Evalution, and Treatment of high blood cholesterol in adult. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults(Adult Treatment Panel Ⅲ). JAMA, 2001, 285 (19): 2486-2497.
  • 7Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol, 1999, 19(2): 187-195.
  • 8Castelli WP. Cholesterol and lipids in the risk of coronary artery disease the Framingham Heart Study. Can J Cardiol, 1988, 4 (Suppl A): 5A-10A.
  • 9中华人民共和国卫生部. 心血管药物临床研究指导原则 (试行). 1988: 86-88.
  • 10Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA, 1993, 269(23): 3009-3014.

共引文献3149

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部